Overview Of Value Stocks In The Technology Sector
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the…
Cellebrite DI Q4 Adj EPS $0.08 Beats $0.04 Estimate, Sales $74.00M Miss $74.73M Estimate
Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.04 by 100 percent. This is a 166.67 percent increase over earnings of $0.03 per share from the
Cellebrite DI Q3 EPS $0.01 Misses $0.02 Estimate, Sales $71.67M Miss $72.13M Estimate
Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.02 by 50 percent. This is a 87.5 percent decrease over earnings of $0.08 per share from the
Earnings Scheduled For November 17, 2022
Companies Reporting Before The Bell
• Jumia Technologies (NYSE:JMIA) is expected to report quarterly loss at $0.76 per share on revenue of $57.32 million.
Overview Of Value Stocks In The Technology Sector
What are Value Stocks?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Expert Ratings for Cellebrite DI
Analysts have provided the following ratings for Cellebrite DI (NASDAQ:CLBT) within the last quarter:
B of A Securities Downgrades Cellebrite DI to Neutral, Lowers Price Target to $6
B of A Securities analyst Tal Liani downgrades Cellebrite DI (NASDAQ:CLBT) from Buy to Neutral and lowers the price target from $6.5 to $6.
Cellebrite DI Q2 Sales $62.60M Miss $69.00M Estimate
Cellebrite DI (NASDAQ:CLBT) reported quarterly sales of $62.60 million which missed the analyst consensus estimate of $69.00 million by 9.28 percent.
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell
• Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.